• Something wrong with this record ?

Laterally Extended Pelvic Resection for Gynaecological Malignancies: A Multicentric Experience with Out-of-the-Box Surgery

G. Vizzielli, R. Naik, L. Dostalek, N. Bizzarri, A. Kucukmetin, G. Tinelli, G. Scambia, D. Cibula,

. 2019 ; 26 (2) : 523-530. [pub] 20181211

Language English Country United States

Document type Journal Article

E-resources Online Full text

NLK Free Medical Journals from 1994 to 24 months ago
ProQuest Central from 1997-01-01 to 1 year ago
Medline Complete (EBSCOhost) from 2009-07-01 to 1 year ago
Health & Medicine (ProQuest) from 1997-01-01 to 1 year ago

PURPOSE: To evaluate morbidity and oncological outcome in a multicentre series of women with gynaecological malignancies infiltrating pelvic side wall (PSW) that received laterally extended pelvic resection (LEPR). METHODS: Patients operated between 2007 and 2017 at three institutions were included. LEPR was defined as an en bloc lateral resection of a pelvic tumour involving sidewall muscle, and/or bone, and/or major nerve, and/or major vascular structure. Postsurgical complications and survivals were evaluated. RESULTS: Sixty-three women with gynaecological tumours involving PSW were treated with LEPR. Five women underwent primary LEPR, whereas 58 (92%) patients needed LEPR because of recurrence. Twenty-four women (38%) received previous radiation therapy before the surgery. R0 resection was achieved in 54 patients (85.7%), whereas the pathologic margins were microscopically and macroscopically positive in 8 (12.7%) patients and 1 (1.6%) patient, respectively. There was one perioperative death, whereas major postoperative complications occurred in 17 patients (27.7%). Thirty (47.5%) women experienced recurrences: 24/54 (44.4%) were in the R0 group, and 6/9 (66.6%) were in the R1 group, with a median PFS of 15 months and 7 months, respectively (p = 0.024). In total, 11 of 54 (20.3%) patients died of disease in the R0 group and 5 of 9 (55.5%) in the R1 group; a median OS was not reached and was 32 months for R0 and R1 groups, respectively (p = 0.033). CONCLUSIONS: Involvement of the PSW should not prevent obtaining R0 resection. Although the LEPR is associated with considerable morbidity (≈ 30%), a long-term survival seems to be achieved in those women with complete resection.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc19027996
003      
CZ-PrNML
005      
20190816101431.0
007      
ta
008      
190813s2019 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1245/s10434-018-07088-8 $2 doi
035    __
$a (PubMed)30539489
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Vizzielli, Giuseppe $u Department of Women's and Children's Health, Fondazione Policlinico Universitario A. Gemelli - IRCCS, Università Cattolica del Sacro Cuore, Rome, Italy. giuseppevizzielli@yahoo.it.
245    10
$a Laterally Extended Pelvic Resection for Gynaecological Malignancies: A Multicentric Experience with Out-of-the-Box Surgery / $c G. Vizzielli, R. Naik, L. Dostalek, N. Bizzarri, A. Kucukmetin, G. Tinelli, G. Scambia, D. Cibula,
520    9_
$a PURPOSE: To evaluate morbidity and oncological outcome in a multicentre series of women with gynaecological malignancies infiltrating pelvic side wall (PSW) that received laterally extended pelvic resection (LEPR). METHODS: Patients operated between 2007 and 2017 at three institutions were included. LEPR was defined as an en bloc lateral resection of a pelvic tumour involving sidewall muscle, and/or bone, and/or major nerve, and/or major vascular structure. Postsurgical complications and survivals were evaluated. RESULTS: Sixty-three women with gynaecological tumours involving PSW were treated with LEPR. Five women underwent primary LEPR, whereas 58 (92%) patients needed LEPR because of recurrence. Twenty-four women (38%) received previous radiation therapy before the surgery. R0 resection was achieved in 54 patients (85.7%), whereas the pathologic margins were microscopically and macroscopically positive in 8 (12.7%) patients and 1 (1.6%) patient, respectively. There was one perioperative death, whereas major postoperative complications occurred in 17 patients (27.7%). Thirty (47.5%) women experienced recurrences: 24/54 (44.4%) were in the R0 group, and 6/9 (66.6%) were in the R1 group, with a median PFS of 15 months and 7 months, respectively (p = 0.024). In total, 11 of 54 (20.3%) patients died of disease in the R0 group and 5 of 9 (55.5%) in the R1 group; a median OS was not reached and was 32 months for R0 and R1 groups, respectively (p = 0.033). CONCLUSIONS: Involvement of the PSW should not prevent obtaining R0 resection. Although the LEPR is associated with considerable morbidity (≈ 30%), a long-term survival seems to be achieved in those women with complete resection.
650    _2
$a dospělí $7 D000328
650    _2
$a senioři $7 D000368
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a následné studie $7 D005500
650    _2
$a nádory ženských pohlavních orgánů $x patologie $x chirurgie $7 D005833
650    _2
$a lidé $7 D006801
650    _2
$a lidé středního věku $7 D008875
650    _2
$a lokální recidiva nádoru $x patologie $x chirurgie $7 D009364
650    12
$a exenterace pánve $7 D010385
650    _2
$a nádory pánve $x patologie $x chirurgie $7 D010386
650    12
$a pooperační komplikace $7 D011183
650    _2
$a retrospektivní studie $7 D012189
650    _2
$a míra přežití $7 D015996
650    _2
$a výsledek terapie $7 D016896
655    _2
$a časopisecké články $7 D016428
700    1_
$a Naik, Raj $u Northern Gynaecological Oncology Centre, Queen Elizabeth Hospital, Gateshead, UK.
700    1_
$a Dostalek, Lukas $u Gynaecologic Oncology Center, Department of Obstetrics and Gynecology, First Faculty of Medicine, Charles University in Prague, General University Hospital in Prague, Prague, Czech Republic.
700    1_
$a Bizzarri, Nicolò $u Northern Gynaecological Oncology Centre, Queen Elizabeth Hospital, Gateshead, UK.
700    1_
$a Kucukmetin, Ali $u Northern Gynaecological Oncology Centre, Queen Elizabeth Hospital, Gateshead, UK.
700    1_
$a Tinelli, Giovanni $u Division of Vascular Surgery, Fondazione Policlinico Universitario A. Gemelli - IRCCS, Università Cattolica del Sacro Cuore, Rome, Italy.
700    1_
$a Scambia, Giovanni $u Department of Women's and Children's Health, Fondazione Policlinico Universitario A. Gemelli - IRCCS, Università Cattolica del Sacro Cuore, Rome, Italy.
700    1_
$a Cibula, David $u Gynaecologic Oncology Center, Department of Obstetrics and Gynecology, First Faculty of Medicine, Charles University in Prague, General University Hospital in Prague, Prague, Czech Republic.
773    0_
$w MED00000441 $t Annals of surgical oncology $x 1534-4681 $g Roč. 26, č. 2 (2019), s. 523-530
856    41
$u https://pubmed.ncbi.nlm.nih.gov/30539489 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20190813 $b ABA008
991    __
$a 20190816101701 $b ABA008
999    __
$a ok $b bmc $g 1433145 $s 1066456
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2019 $b 26 $c 2 $d 523-530 $e 20181211 $i 1534-4681 $m Annals of surgical oncology $n Ann Surg Oncol $x MED00000441
LZP    __
$a Pubmed-20190813

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...